Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • statsteam
    Member
    • Sep 2009
    • 19

    Cufflinks, differentially expressed genes

    Hi,

    I am trying to run edgeR or DEGseq using the output from cufflinks.
    I usually use mapped reads count as an input to edgeR or DEGseq. What cufflinks output do I need to use for an input to edgeR or DEGseq? I am thinking about adding "coverage" of each isoform for a gene from isoforms.fpkm_tracking file. Does this make sense?

    Thank you!
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    edgeR and DEGseq take raw counts. They then do their own normalizations. Taking results from cufflinks and trying to use this in any of these programs is not a good approach, even though a lot of people try it for some reason. If you want to use the output of Cufflinks for differential expression, then I would stick to the Cufflinks pipeline and use Cuffdiff.

    Otherwise, extract read counts for each gene from your bam/sam/bed file and use this as input for edgeR/DEGseq.

    Comment

    • statsteam
      Member
      • Sep 2009
      • 19

      #3
      I agree that we'd better stick to cuffdiff for differentially expressed gene analysis. Doe cuffdiff have "paired"-analysis feature for the data with replicates? The paired-analysis feature is the main reason I want to use edgeR.

      Comment

      • Thomas Doktor
        Senior Member
        • Apr 2009
        • 105

        #4
        Cuffdiff supports replicates but does not handle paired replicates to my knowledge.

        Btw, I would recommend using DESeq instead of DEGseq, the spelling is similar but the internal statistical modelling is very different.
        Last edited by Thomas Doktor; 02-02-2012, 04:14 AM.

        Comment

        • dietmar13
          Senior Member
          • Mar 2010
          • 107

          #5
          how many replicates in each condition do you have?

          you could also use SAMseq (samr v2 R-package). this package works with many kinds of designs: paired, quantitative, right censored (like overall survival).
          in my hands, SAMseq produced most significant genes (followed by edgeR, baySeq, DESeq, NOIseq, and far far behind cuffdiff) , which were rather robust in bootstrap validations.

          my design: 12 normal vs 12 cancer (paired, means from the same patient).

          Comment

          • IBseq
            Member
            • Jul 2012
            • 56

            #6
            Hello guys,
            if anyone knows, could you please tell me why is this happening:

            i ran cufflinks on galaxy with default parameters and had satisfactory results.
            I then ran the same samples with same parameters except changing max intron length from 300000 to 600000

            in the second run have the exact number of transcripts but the FPKM values are much much lower..

            Any suggestion?

            Thanks,
            ibseq

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM
            • GATTACAT
              Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
              by GATTACAT
              Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
              07-01-2026, 11:43 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-07-2026, 11:05 AM
            0 responses
            34 views
            0 reactions
            Last Post SEQadmin2  
            Working...